Share this
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
January 9, 2023
Oculis and European Biotech Acquisition Corp. Announce Business Combination Agreement
October 25, 2022
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
December 16, 2021
Adagio Therapeutics Raises $336 Million Series C for COVID-19 Treatment and Prevention
May 20, 2021
ArTara Agrees to Combine With Proteon
Transaction to create Nasdaq-listed rare and specialty disease therapeutic company • September 27, 2019
Therachon Agrees to Sell to Pfizer for Up to $810 Million
May 21, 2019
Aquestive – $74 Million IPO
September 12, 2018
Agilis Biotherapeutics Sells to PTC for $200 Million
Combination expands gene therapy programs for treatment of rare diseases • July 30, 2018
NEA Leads $50 Million Series C for Trevi Therapeutics
September 1, 2017
Cooley Enhances Corporate Life Sciences Capabilities
Boston office grows as 10th anniversary of New England launch approaches • March 2, 2017